Primary Care Providers’ Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening
Decision aids are tools intended to help people weigh the benefits and harms of a health decision. We examined primary care providers’ perspective on use of decision aids and explored whether providers’ beliefs and interest in use of a decision aid was associated with offering the prostate-specific antigen (PSA) test for early detection of prostate cancer. Data were obtained from 2016 DocStyles, an annual, web-based survey of U.S. healthcare professionals including primary care physicians (n = 1003) and nurse practitioners (n = 253). We found that the majority of primary care providers reported not using (patient) decision aids for prostate cancer screening, but were interested in learning about and incorporating these tools in their practice. Given the potential of decision aids to guide in informed decision-making, there is an opportunity for evaluating existing decision aids for prostate cancer screening for clinical use.
KeywordsProstate cancer Prostate specific antigen Decision aids Prostate cancer screening
All authors are federal government employees, and the preparation of the manuscript was entirely funded by the U.S. government.
Compliance with Ethical Standards
Conflict of Interest
The authors declare they have no conflict of interest.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
- 2.Wolf AM, Wender RC, Etzioni RB, Thompson IM, D’Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA, American Cancer Society Prostate Cancer Advisory Committee (2010) American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 60(2):70–98CrossRefPubMedGoogle Scholar
- 3.Stacey D, Legare F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R et al:(2014)Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (1):CD001431Google Scholar
- 4.Taylor KL, Williams RM, Davis K, Luta G, Penek S, Barry S, Kelly S, Tomko C, Schwartz M, Krist AH, Woolf SH, Fishman MB, Cole C, Miller E (2013) Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. JAMA Intern Med 173(18):1704–1712PubMedPubMedCentralGoogle Scholar
- 7.Poghosyan L, Lucero R, Rauch L, Berkowitz B: Nurse practitioner workforce: a substantial supply of primary care providers. Nurs Econ 2012;30(5):268–274, 294Google Scholar
- 13.United States Preventive Services Task Force. Prostate cancer screening draft recommendations. https://screeningforprostatecancer.org, Accessed date: 1 Nov 2017
- 14.Chou R, Dana T, Bougatsos C, Fu R, Blazina I, et al.: Treatments for localized prostate cancer: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation. Evidence Synthesis No. 91. AHRQ Publication No. 12–05161-EF-2. Rockville, MD: Agency for Healthcare Research and Quality; 2011Google Scholar
- 16.Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D, Wender RC, Brawley OW (2014) Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 64(1):30–51CrossRefPubMedGoogle Scholar